Rothschild Investment Corp Biomarin Pharmaceutical Inc Transaction History

Rothschild Investment Corp

$1.19 Billion
Q3 2023

A detailed history of Rothschild Investment Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Rothschild Investment Corp holds 14,304 shares of BMRN stock, worth $931,047. This represents 0.11% of its overall portfolio holdings.

Number of Shares

14,304

Previous 15,004 4.67%

Holding current value

$931,047

Previous $1.3 Million 2.69%

% of portfolio

0.11%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$85.07 - $94.48 $59,548 - $66,136	-700 Reduced 4.67%	14,304 $1.27 Million
Q2 2023 Jul 18, 2023	SELL	$86.68 - $100.3 $13,088 - $15,145	-151 Reduced 1.0%	15,004 $1.3 Million
Q1 2023 Apr 24, 2023	SELL	$87.74 - $117.27 $8,686 - $11,609	-99 Reduced 0.65%	15,155 $1.47 Million
Q4 2022 Jan 19, 2023	SELL	$80.93 - $108.63 $32,857 - $44,103	-406 Reduced 2.59%	15,254 $1.58 Million
Q3 2022 Oct 21, 2022	BUY	$82.16 - $96.94 $4,600 - $5,428	56 Added 0.36%	15,660 $1.33 Million
Q2 2022 Jul 12, 2022	BUY	$71.48 - $86.85 $75,054 - $91,192	1,050 Added 7.21%	15,604 $1.29 Million
Q4 2021 Jan 24, 2022	BUY	$71.72 - $91.47 $34,497 - $43,997	481 Added 3.42%	14,554 $1.29 Million
Q3 2021 Oct 12, 2021	SELL	$74.77 - $85.47 $22,431 - $25,641	-300 Reduced 2.09%	14,073 $1.09 Million
Q2 2021 Jul 19, 2021	SELL	$75.51 - $84.79 $32,091 - $36,035	-425 Reduced 2.87%	14,373 $1.2 Million
Q1 2021 Apr 15, 2021	BUY	$74.73 - $90.69 $14,946 - $18,138	200 Added 1.37%	14,798 $1.12 Million
Q4 2020 Jan 25, 2021	BUY	$72.61 - $90.2 $11,762 - $14,612	162 Added 1.12%	14,598 $1.28 Million
Q3 2020 Oct 22, 2020	SELL	$71.87 - $131.03 $206,985 - $377,366	-2,880 Reduced 16.63%	14,436 $1.1 Million
Q2 2020 Jul 24, 2020	SELL	$79.55 - $124.22 $78,993 - $123,350	-993 Reduced 5.42%	17,316 $2.14 Million
Q1 2020 Apr 16, 2020	SELL	$71.37 - $96.85 $29,261 - $39,708	-410 Reduced 2.19%	18,309 $1.55 Million
Q4 2019 Jan 22, 2020	BUY	$64.27 - $86.37 $96,405 - $129,555	1,500 Added 8.71%	18,719 $1.58 Million
Q3 2019 Oct 11, 2019	SELL	$67.4 - $85.11 $26,960 - $34,044	-400 Reduced 2.27%	17,219 $1.16 Million
Q2 2019 Jul 11, 2019	BUY	$80.35 - $93.9 $368,404 - $430,531	4,585 Added 35.18%	17,619 $1.51 Million
Q1 2019 Apr 18, 2019	BUY	$84.2 - $98.62 $8,420 - $9,862	100 Added 0.77%	13,034 $1.16 Million
Q4 2018 Jan 28, 2019	SELL	$80.14 - $106.07 $8,014 - $10,607	-100 Reduced 0.77%	12,934 $1.1 Million
Q3 2018 Oct 17, 2018	SELL	$93.92 - $105.72 $62,456 - $70,303	-665 Reduced 4.85%	13,034 $1.26 Million
Q1 2018 Apr 27, 2018	BUY	$77.67 - $92.63 $491,651 - $586,347	6,330 Added 85.9%	13,699 $1.11 Million
Q4 2017 Jan 23, 2018	BUY	$80.76 - $95.13 $595,120 - $701,012	7,369	7,369 $657,000

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.

Account

Rothschild Investment Corp Biomarin Pharmaceutical Inc Transaction History